1.LINC00636 regulates the proliferation and migration of non-small cell lung cancer cells by targeting NM23-H1
Zhansheng LU ; Qingbin ZHANG ; Xiaojiang ZHOU ; Jian HU ; Jing YAO ; Weijuan TANG
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery 2026;33(11):1832-1941
Objective To explore the mechanism by which LINC00636 promotes the proliferation and metastasis of non-small cell lung cancer (NSCLC) by targeting NM23-H1. Methods A retrospective analysis was performed on the clinical data of patients with NSCLC who received surgical treatment at Guizhou Provincial People's Hospital from 2021 to 2022. Based on the Affymetrix® GeneChip Human Transcriptome Array 2.0 (HTA2.0), differentially expressed long non-coding RNA (lncRNA) in three pairs of NSCLC tissues with and without lymph node metastasis were analyzed, and LINC00636 was selected as the candidate gene. The effects of LINC00636 knockdown and overexpression on the proliferation, apoptosis, migration and subcutaneous tumorigenicity of PC9 cells were analyzed. The dual-luciferase assay was used to analyze the targeting regulation of LINC00636 on NM23-H1. Results A total of 59 patients were enrolled, including 38 males and 21 females, with a mean age of (56.0±5.6) years. Fifteen patients presented with lymph node metastasis. The expression of LINC00636 in the serum and tissues of NSCLC patients with lymph node metastasis was higher than that in patients without lymph node metastasis. Overexpression of LINC00636 could promote the migration and proliferation of NSCLC cells. LINC00636 could target and regulate the expression of NM23-H1, and the expression of LINC00636 and NM23-H1 in NSCLC tissues and cells was negatively correlated. The inhibitory effect of NM23-H1 on the proliferation and migration of PC9 cells could be partially reversed by LINC00636 overexpression. Conclusion LINC00636 promotes the proliferation and migration of NSCLC cells by inhibiting the expression of NM23-H1 and is a potential prognostic marker and therapeutic target for NSCLC.
2.Comparison of the efficacy of modified Chevron osteotomy and Scarf osteotomy in the treatment of moderate to severe hallux valgus
Zhansheng LI ; Junbo WANG ; Tan LU
Journal of Xinxiang Medical College 2024;41(11):1032-1037
Objective To compare the efficacy of modified Chevron osteotomy and Scarf osteotomy in the treatment of moderate to severe hallux valgus.Methods A total of 76 patients with moderate to severe hallux valgus admitted to the Department of Hand and Foot Microsurgery,the First Affiliated Hospital of Xinxiang Medical University from January 2018 to January 2022 were selected as the research subjects.According to the surgical method,the patients were divided into modified Chevron osteotomy group(n=39,41 feet)and Scarf osteotomy group(n=37 feet).The patients in the modified Chevron osteotomy group received modified Chevron osteotomy treatment,the patients in the Scarf osteotomy group received Scarf osteotomy treatment.The hallux valgus angle(HVA),the 1st and 2nd inter metatarsal angle(IMA)and the distal metatarsal articular angle(DMAA)under weight-bearing conditions of patients in the two groups before and 6 months after surgery were recorded.The orthopedic effect of patients was evaluated by using the American Orthopaedic Foot and Ankle Society(AOFAS)score,and the pain level of patients was evaluated by using the visual analogue scale(VAS)score before and 6 months after surgery.The osteotomy healing time and postoperative complications of patients were compared between the two groups.Results There was no statistically significant difference in HVA,IMA,DMAA and AOFAS,VAS scores of patients before and 6 months after surgery between the two groups(P>0.05).Six months after surgery,the HVA,IMA,and DM A A of patients in the two groups were significantly lower than those before surgery(P<0.05),the AOFAS score was significantly higher than that before surgery(P<0.05),and the VAS score was significantly lower than that before surgery(P<0.05).The osteotomy healing time of patients in the modified Chevron osteotomy group and Scarf osteotomy group was(3.23±0.49)and(3.49±0.69)months,respectively;there was no statistically significant difference in the osteotomy healing time of patients between the two groups(t=-1.874,P>0.05).The patients in both groups did not experience any vascular or nerve damage during the surgery,the surgical incision and osteotomy healed in one stage,and there were no complications such as incision infection,delayed osteotomy healing,or nonunion.Two patients(4.9%)in the modified Chevron osteotomy group experienced postoperative metastatic metatarsal pain,and the symptoms were significantly improved after treatment with targeted therapies such as blocking and physical therapy.One patient in each of the two groups experienced discomfort caused by loose internal fixation.The recurrence rates of hallux valgus in the modified Chevron osteotomy group and Scarf osteotomy group were 19.5%(8/41)and 2.6%(1/38),respectively;the recurrence rate of hallux valgus in the Scarf osteotomy group was significantly lower than that in the modified Chevron osteotomy group(x2=5.567,P<0.05).Conclusion The modified Chevron osteotomy and Scarf osteotomy have similar therapeutic effects in correcting deformities,improving ankle function,and alleviating pain in the treatment of moderate to severe hallux valgus,and both surgical methods have few postoperative complications.However,the recurrence rate of hallux valgus after modified Chevron osteotomy is significantly higher than that after Scarf osteotomy.
3.Construction and Expression of nm23-H1 Gene with Different Enzyme Activities and Resistant Speciifc shRNA in Eukaryotic Expression Vector
LU ZHANSHENG ; GUO LILI ; LI LIN ; WU ZHIHAO ; ZHOU QINGHUA
Chinese Journal of Lung Cancer 2014;(3):183-188
Background and objective It has been proven that nm23-H1 gene was a tumor metastatic suppressor gene. However, it’s molecular mechanism of suppressing metastasis remains unexplored. hTere is a closely relationship between the abnormality of stucturs and functions of nm23-H1 gene, and cancer invasion and metastasis. We have constructed the vec-tor with nm23-H1-shRNA and the vector with nm23-H1cDNA resistant to the speciifc shRNA. So, we plan to construct shR-NA-resistant eukaryotic expression vector of nm23-H1 gene by site-directed mutagenesis, rescue experiment was performed to verify the nm23-H1 gene expression, and to provide basement for studying the biochemical mechanisms of nm23-H1 gene. Methods Site-directed mutagenesis of nm23-H1 gene was performed by overlap extension PCR method. Pure plasmid con-taining gene of nm23-H1 (shRNA-resistant) was prepared. hTe desired ifve mutations were constructed and cloned into the eukaryotic vector pcDNA3.1Hygro(+). hTe human lung adenocarcinoma cell A549/nm23-H1-shRNA (stable nm23-H1 gene silencing) was transfected with the ifve mutants, and the expression of the mutant proteins was determined by Western blot. Results Five eukaryotic expression vectors (shRNA-resistant) of nm23-H1, nm23-H1S44A, nm23-H1P96S, nm23-H1H118F, nm23-H1S120G, nm23-H1P96S-S120G, were successfully constructed. hTe results of DNA sequencing conifrmed that the base sequences of the genes were completely concordant with experiment design. hTe expression of nm23-H1 mutant proteins was veriifed by Western blot. Conclusion Five eukaryotic expression vectors (shRNA-resistant) of nm23-H1 gene were successfully con-structed, and the mutant proteins were veriifed. hTe site-directed mutagenesis technical of overlap extension PCR is a effcient, simple and economical method.

Result Analysis
Print
Save
E-mail